AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 69(5 suppl), 2003, pp. 1-10
Copyright © 2003 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FRICK, K. D.
Right arrow Articles by JACOBSON, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FRICK, K. D.
Right arrow Articles by JACOBSON, G. A.

GLOBAL BURDEN OF TRACHOMA AND ECONOMICS OF THE DISEASE

KEVIN D. FRICK, CHRISTY L. HANSON, AND GRETCHEN A. JACOBSON
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; Health Services Research and Development Center, Department of Economics, Department of Ophthalmology, and Department of International Health, Johns Hopkins University, Baltimore, Maryland

Interest in the economics of trachoma is high because of the refinement of a strategy to control trachomatous blindness, an ongoing global effort to eliminate incident blindness from trachoma by 2020, and an azithromycin donation program that is a component of trachoma control programs in several countries. This report comments on the economic distribution of blindness from trachoma and adds insight to published data on the burden of trachoma and the comparative costs and effects of trachoma control. Results suggest that 1) trichiasis without visual impairment may result in an economic burden comparable to trachomatous low vision and blindness so that 2) the monetary burden of trachoma may be 50% higher than conservative, published figures; 3) within some regions more productive economies are associated with less national blindness from trachoma; and 4) the ability to achieve a positive net benefit of trachoma control depends importantly on the cost per dose of antibiotic.


Received July 30, 2003. Accepted for publication August 29, 2003.

Acknowledgments: We thank Jeff Mecaskey for comments on an earlier version of this paper, his input on the concept of equity and trachoma, and his continued interest in the economics of trachoma.

Financial support: The work on this paper was supported by a grant from the International Trachoma Initiative.

Authors’ addresses: Kevin D. Frick, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 North Broadway, Room 606, Baltimore MD 21205-1901, Telephone: 410-614-4018, Fax: 410-955-0470, E-mail: kfrick{at}jhsph.edu. Christy L. Hanson, PO Box 27794 Washington, DC 20038, Telephone: 202-458-2159, Fax: 202-473-8107, E-mail: chanson{at}jhsph.edu. Gretchen A. Jacobson, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 North Broadway, Room 654, Baltimore MD 21205-1901, Telephone: 410-955-6562, Fax: 410-955-0470, E-mail: gjacobso{at}jhsph.edu.

Reprint requests: Kevin D. Frick, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 North Broadway, Room 606, Baltimore MD 21205-1901.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society of Tropical Medicine and Hygiene.